Linked Life Data

21060271

Source:http://linkedlifedata.com/resource/pubmed/id/21060271

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2010-11-9
pubmed:abstractText
The purpose of this study was to determine the efficacy and safety of intravitreal infliximab in the treatment of choroidal neovascularization secondary to age-related macular degeneration in patients who are nonresponders to antivascular endothelial growth factor therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1539-2864
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1601-8
pubmed:meshHeading
pubmed-meshheading:21060271-Aged, pubmed-meshheading:21060271-Aged, 80 and over, pubmed-meshheading:21060271-Angiogenesis Inhibitors, pubmed-meshheading:21060271-Anti-Inflammatory Agents, pubmed-meshheading:21060271-Antibodies, Monoclonal, pubmed-meshheading:21060271-Female, pubmed-meshheading:21060271-Fluorescein Angiography, pubmed-meshheading:21060271-Humans, pubmed-meshheading:21060271-Intravitreal Injections, pubmed-meshheading:21060271-Male, pubmed-meshheading:21060271-Prospective Studies, pubmed-meshheading:21060271-Tomography, Optical Coherence, pubmed-meshheading:21060271-Treatment Failure, pubmed-meshheading:21060271-Treatment Outcome, pubmed-meshheading:21060271-Vascular Endothelial Growth Factor A, pubmed-meshheading:21060271-Visual Acuity, pubmed-meshheading:21060271-Wet Macular Degeneration
pubmed:articleTitle
Intravitreal infliximab in patients with macular degeneration who are nonresponders to antivascular endothelial growth factor therapy.
pubmed:affiliation
Department of Ophthalmology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain. luisarias@telefonica.net
pubmed:publicationType
Journal Article, Case Reports